United-Guardian, Inc.

UG

US9105711082

Pharmaceuticals

Market Closed - Nasdaq Other stock markets 02:00:00 04/06/2024 am IST			5-day change	1st Jan Change
9.161 ^USD	-1.70%		+3.24%	+27.24%

21/05	United-Guardian, Inc. Appoints Denise Costrini as Marketing Director	CI
15/05	Transcript : United-Guardian, Inc. - Shareholder/Analyst Call

United-Guardian Inc. Announces Resignation of Christopher W. Nolan as Director

October 06, 2015 at 08:09 pm IST

On October 2, 2015, Christopher W. Nolan, a director of United-Guardian Inc., notified the company that he was resigning from the company's Board of Directors effective immediately.

Latest news about United-Guardian, Inc.

United-Guardian, Inc. Appoints Denise Costrini as Marketing Director	21/05	CI
Transcript : United-Guardian, Inc. - Shareholder/Analyst Call	15/05
Earnings Flash (UG) UNITED-GUARDIAN Reports Q1 Revenue $3.3M	11/05	MT
Earnings Flash (UG) UNITED-GUARDIAN Posts Q1 EPS $0.20	11/05	MT
United-Guardian, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	11/05	CI
United-Guardian, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	22/03	CI
United-Guardian, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	22/03	CI
Global markets live: Meta, Amazon, Apple, Tesla, Intel...	02/02
United-Guardian Increases Dividend to $0.25 a Share, Payable Feb. 20 to Stockholders of Record Feb. 12; Shares up 5.1%	02/02	MT
United-Guardian, Inc. Declares Cash Dividend, Payable on February 20, 2024	02/02	CI
United-Guardian Appoints Catherine Joy Kolinski as Director	08/01	CI
Earnings Flash (UG) UNITED-GUARDIAN Posts Q3 Revenue $3.1M	06/11	MT
Earnings Flash (UG) UNITED-GUARDIAN Reports Q3 EPS $0.14	06/11	MT
United-Guardian, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	06/11	CI
Earnings Flash (UG) UNITED-GUARDIAN Reports Q2 Revenue $2.7M	11/23/11	MT
United-Guardian, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	11/23/11	CI
United-Guardian Declares Mid-Year Dividend, Payable on June 1, 2022	14/23/14	CI
United-Guardian, Inc. Declares Cash Dividend, Payable on August 2, 2023	14/23/14	CI
United-Guardian, Inc. Announces Resignation of Beatriz Blanco as Chief Executive Officer	14/23/14	CI
United-Guardian, Inc. Announces Beatriz Blanco Would Be Ending Her Employment as President of the Company	14/23/14	CI
United-Guardian, Inc. Appoints Donna Vigilante as President	14/23/14	CI
Transcript : United-Guardian, Inc. - Shareholder/Analyst Call	17/23/17
Earnings Flash (UG) UNITED-GUARDIAN Posts Q1 EPS $0.16	11/23/11	MT
Earnings Flash (UG) UNITED-GUARDIAN Posts Q1 Revenue $2.6M	11/23/11	MT
United-Guardian, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	11/23/11	CI

United-Guardian, Inc. is engaged in manufacturing and marketing cosmetic ingredients, pharmaceutical products, medical lubricants and sexual wellness ingredients. Cosmetic ingredients include a line of multifunctional hydrogel formulations designed to offer sensory enhancement, lubrication, texture and moisturization to personal care products. Its cosmetic ingredients include Lubrajel Natural, Lubrajel Marine, Lubrajel Oil Natural and Lubrajel Terra. Medical lubricants include a line of hydrogel formulations designed to offer sensory enhancement and lubrication to medical products. Pharmaceutical products include an FDA approved prescription drug that is used primarily to prevent and to dissolve calcifications in urethral catheters, as well as a chlorine-based topical antimicrobial. Sexual wellness ingredients include a line of hydrogel formulations designed to offer sensory enhancement, lubrication and moisturization to sexual wellness applications.

Sector

Pharmaceuticals

Calendar

09/08/2024 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Other Pharmaceuticals

	1st Jan change	Capi.
UNITED-GUARDIAN, INC.	+27.24%	42.09M
ELI LILLY AND COMPANY	+42.60%	748B
NOVO NORDISK A/S	+33.12%	598B
JOHNSON & JOHNSON	-5.74%	356B
MERCK & CO., INC.	+17.79%	325B
ABBVIE INC.	+3.37%	283B
ASTRAZENECA PLC	+17.19%	245B
NOVARTIS AG	+9.14%	211B
ROCHE HOLDING AG	-3.80%	209B
AMGEN INC.	+6.74%	165B